碳青霉烯耐药伊丽莎白金菌的氟喹诺酮耐药机制与基因组特征
研究分析了115株临床分离的碳青霉烯耐药伊丽莎白金菌,所有菌株均携带blaGOB和blaB基因。药敏试验显示多数菌株对环丙沙星和左氧氟沙星耐药模式不同,测序证实GyrA热点区Ser83Ile或Ser83Arg突变主要导致高水平氟喹诺酮耐药。米诺环素或环丙沙星可能用于治疗严重感染。
要点
- 碳青霉烯耐药伊丽莎白金菌均携带blaGOB和blaB基因。
- GyrA Ser83Ile/Arg突变是高水平氟喹诺酮耐药的主要机制。
- 米诺环素或环丙沙星或可用于严重感染治疗。
核心结论
- 碳青霉烯耐药伊丽莎白金菌的氟喹诺酮耐药与GyrA QRDR突变强相关,米诺环素或环丙沙星具有治疗潜力。
研究设计与样本
- 对115株非重复临床分离的伊丽莎白金菌进行药敏试验、PCR检测QRDR突变和MBL基因,并用联合纸片法筛查MBL产生。
主要发现
- 所有菌株均携带blaGOB和blaB基因,对碳青霉烯类耐药。
- 多数菌株对环丙沙星和左氧氟沙星呈现不同耐药模式。
- 测序证实GyrA热点区Ser83Ile或Ser83Arg突变主要导致高水平环丙沙星/左氧氟沙星耐药。
- 仅一株菌无QRDR突变但氟喹诺酮MIC高。
关键数值与推荐
- 115株非重复临床分离株中,所有菌株均携带blaGOB和blaB基因。
- GyrA Ser83Ile或Ser83Arg突变主要导致高水平环丙沙星/左氧氟沙星耐药。
临床怎么用
- 对碳青霉烯耐药伊丽莎白金菌感染,可考虑米诺环素或环丙沙星治疗严重感染。
- 临床应关注GyrA突变导致的氟喹诺酮耐药,并加强耐药监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: MDR Elizabethkingia anophelis strains are implicated in an increasing number of healthcare-associated infections worldwide, including a recent cluster of E. anophelis infections in the Midwestern USA associated with significant morbidity and mortality. However, there is minimal information on the antimicrobial susceptibilities of E. anophelis strains or their antimicrobial resistance to carbapenems and fluoroquinolones. OBJECTIVES: Our aim was to examine the susceptibilities and genetic profiles of clinical isolates of E. anophelis from our hospital, characterize their carbapenemase genes and production of MBLs, and determine the mechanism of fluoroquinolone resistance. METHODS: A total of 115 non-duplicated isolates of E. anophelis were examined. MICs of antimicrobial agents were determined using the Sensititre 96-well broth microdilution panel method. QRDR mutations and MBL genes were identified using PCR. MBL production was screened for using a combined disc test. RESULTS: All E. anophelis isolates harboured the blaGOB and blaB genes with resistance to carbapenems. Antibiotic susceptibility testing indicated different resistance patterns to ciprofloxacin and levofloxacin in most isolates. Sequencing analysis confirmed that a concurrent GyrA amino acid substitution (Ser83Ile or Ser83Arg) in the hotspots of respective QRDRs was primarily responsible for high-level ciprofloxacin/levofloxacin resistance. Only one isolate had no mutation but a high fluoroquinolone MIC. CONCLUSIONS: Our study identified a strong correlation between antibiotic susceptibility profiles and mechanisms of fluoroquinolone resistance among carbapenem-resistant E. anophelis isolates, providing an important foundation for continued surveillance and epidemiological analyses of emerging E. anophelis opportunistic infections. Minocycline or ciprofloxacin has the potential for treatment of severe E. anophelis infections.
引用
- Jian MJ, Cheng YH, Chung HY, et al. Fluoroquinolone resistance in carbapenem-resistant Elizabethkingia anophelis: phenotypic and genotypic characteristics of clinical isolates with topoisomerase mutations and comparative genomic analysis. J Antimicrob Chemother. 2019. PMID: 30830171. doi:10.1093/jac/dkz045
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。